Literature DB >> 23710833

Nerve stimulation for chronic pelvic pain and bladder pain syndrome: a systematic review.

Seema A Tirlapur1, Antonis Vlismas, Elizabeth Ball, Khalid S Khan.   

Abstract

Chronic pelvic pain (CPP) and bladder pain syndrome (BPS) can have a negative impact on quality of life. Neuromodulation has been suggested as a possible treatment for refractory pain. To assess the effectiveness of tibial and sacral nerve stimulation in the treatment of BPS and CPP. We searched until July 2012: the Cochrane Library, EMBASE (1980-2012), Medline (1950-2012), Web of knowledge (1900-2012), LILACS (1982-2012) and SIGLE (1990-2012) with no language restrictions. We manually searched through bibliographies and conference proceedings of the International Continence Society. Randomized and prospective quasi-randomized controlled studies vs. sham nerve stimulation treatment or usual care of patients with CPP and BPS who underwent sacral or tibial nerve stimulation were included. Any studies involving transcutaneous stimulation were excluded. The outcome was a cure or improvement in symptoms. Three studies with 169 patients treated with tibial nerve stimulation were included; two for CPP and one for BPS. There were improvements in pain, urinary and quality of life scores. There were no reported data for sacral nerve stimulation. There is scanty literature reporting variable success of posterior tibial nerve stimulation in improving pain, urinary symptoms and quality of life in CPP and BPS. In view of the dearth of quality literature, a large multi-centered clinical trial investigating the effectiveness of electrical nerve stimulation to treat BPS and CPP along with the cost-analysis of this treatment is recommended.
© 2013 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Chronic pelvic pain; bladder pain syndrome; posterior tibial nerve stimulation; sacral nerve stimulation

Mesh:

Year:  2013        PMID: 23710833     DOI: 10.1111/aogs.12184

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  12 in total

1.  New directions in the treatment of pelvic pain.

Authors:  Mercy A Udoji; Timothy J Ness
Journal:  Pain Manag       Date:  2013-09

Review 2.  Role of sacral neuromodulation in modern urogynaecology practice: a review of recent literature.

Authors:  Samina Tahseen
Journal:  Int Urogynecol J       Date:  2018-01-04       Impact factor: 2.894

3.  Sacral neuromodulation treating chronic pelvic pain: a meta-analysis and systematic review of the literature.

Authors:  Amr Mahran; Gina Baaklini; Daisy Hassani; Hassan A Abolella; Ahmed S Safwat; Mandy Neudecker; Adonis K Hijaz; Sangeeta T Mahajan; Steven W Siegel; Sherif A El-Nashar
Journal:  Int Urogynecol J       Date:  2019-03-14       Impact factor: 2.894

Review 4.  Does central sensitization help explain idiopathic overactive bladder?

Authors:  W Stuart Reynolds; Roger Dmochowski; Alan Wein; Stephen Bruehl
Journal:  Nat Rev Urol       Date:  2016-06-01       Impact factor: 14.432

Review 5.  Anorectal and Pelvic Pain.

Authors:  Adil E Bharucha; Tae Hee Lee
Journal:  Mayo Clin Proc       Date:  2016-10       Impact factor: 7.616

Review 6.  Does TENS Reduce the Intensity of Acute and Chronic Pain? A Comprehensive Appraisal of the Characteristics and Outcomes of 169 Reviews and 49 Meta-Analyses.

Authors:  Carole A Paley; Priscilla G Wittkopf; Gareth Jones; Mark I Johnson
Journal:  Medicina (Kaunas)       Date:  2021-10-04       Impact factor: 2.430

7.  Benzodiazepines Suppress Neuromodulatory Effects of Pudendal Nerve Stimulation on Rat Bladder Nociception.

Authors:  Timothy J Ness; Jamie McNaught; Buffie Clodfelder-Miller; Dwight E Nelson; Xin Su
Journal:  Anesth Analg       Date:  2020-04       Impact factor: 5.108

Review 8.  Neuromodulation for Chronic Pelvic Pain.

Authors:  Justina Tam; Charles Loeb; Daniel Grajower; Jason Kim; Steven Weissbart
Journal:  Curr Urol Rep       Date:  2018-03-26       Impact factor: 3.092

9.  Outcomes of sacral neuromodulation for chronic pelvic pain: a Finnish national multicenter study.

Authors:  A Zegrea; J Kirss; T Pinta; T Rautio; P Varpe; M Kairaluoma; M Aho; C Böckelman; M Lavonius
Journal:  Tech Coloproctol       Date:  2020-01-21       Impact factor: 3.781

10.  Medications used to treat bladder disorders may alter effects of neuromodulation.

Authors:  Timothy J Ness; Jamie McNaught; Buffie Clodfelder-Miller; Xin Su
Journal:  Neurourol Urodyn       Date:  2020-04-24       Impact factor: 2.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.